SEC Form 4 · accession 0001127602-17-025322
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McCune Rice Jr.
Director
Period of report
Aug 8, 2017
Accepted (ET)
Aug 9, 2017 · 1:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $13.55 | Aug 8, 2017 | A | 12,000 | A | — | Aug 8, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1This award vests 25% every 40 days from the date of grant.